Acute Myeloid Leukemia is a clonal disorder caused by malignant transformation of a bone marrow-derived, self-renewing stem cell or progenitor. This leads to a decreased rate of self-destruction and aberrant differentiation causing an accumulation in the organs and bone marrow by these myeloid cells. The development of Acute Myeloid Leukemia has been associated with many predisposition syndromes that are caused by chromosomal imbalances, DNA repair defects, altered protein synthesis and altered cytokine receptors or signal transduction pathways.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Acute Myeloid Leukemia (aml-m2) below!
For more information on how to use Laverne, please read the How to Guide.
We have 1182 products for the study of Acute Myeloid Leukemia (aml-m2) that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Acute Myeloid Leukemia (aml-m2) is also known as Acute Granulocytic Leukemia With Maturation, Acute Myeloblastic Leukemia M2, Acute Myeloblastic Leukemia With Maturation, Acute Myelocytic Leukemia With Maturation, Acute Myelogenous Leukemia With Maturation.